Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
Presentation ESC 2017 Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Presenter: Robert Giugliano August 28, 2017
Presentation ESC 2017 Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease Presenter: Paul M. Ridker August 27, 2017
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
Presentation ESC 2017 Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial Presenter: David Erlinge August 27, 2017
Presentation ESC 2017 Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction Presenter: Dragana Radovanovic August 26, 2017
Presentation ESC 2017 Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization Presenter: Afnan Tariq August 26, 2017
Presentation EuroPCR 2017 Safety of Coronary Revascularisation Deferral Based on iFR and FFR Measurements in Stable Angina and Acute Coronary Syndromes Presenter: Javier Escaned May 17, 2017
Presentation TCT 2016 Absolute Measurements of Microvascular Resistance by Thermodilution: First Human Data Presenter: Javier Escaned, Amir Lerman, Bernard De Bruyne October 31, 2016
Presentation TCT 2016 Absolute Measurements of Microvascular Resistance by Thermodilution: Principle and Practicalities Presenter: Javier Escaned, Amir Lerman, Nico H.J. Pijls October 31, 2016
Presentation TCT 2016 The Index of Microvascular Resistance Presenter: Javier Escaned, Amir Lerman, William F. Fearon October 31, 2016
Presentation TCT 2016 Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis Presenter: Javier Escaned, Amir Lerman, Keith G. Oldroyd October 31, 2016
Presentation TCT 2016 TCT 48: Medical Therapy and Clinical Outcomes With Spontaneous Coronary Artery Dissection Presenter: Javier Escaned, Christoph K. Naber, Jaya Chandrasekhar October 31, 2016
Presentation TCT 2016 TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Over Two Decades Presenter: Javier Escaned, Christoph K. Naber, Duk-Woo Park October 31, 2016
Presentation TCT 2016 TCT 46: Coronary Artery Aneurysms: Incididence, Etiology, Management, and Outcomes in a Long-term Follow-up Presenter: Javier Escaned, Christoph K. Naber, Antonio Gomez Menchero October 31, 2016
Presentation TCT 2016 TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Reentry vs Wire Escalation Techniques Presenter: Christopher E. Buller, Sudhir Rathore, Lorenzo Azzalini October 31, 2016
Presentation TCT 2016 Spain Presents: Detection and Treatment of Flow-Limiting Lesions in ACS Patients Presenter: Murat Sezer, Niels van Royen, Javier Escaned October 31, 2016
Presentation TCT 2016 Summary and Rationale For the ESC Guidelines on DAPT Duration After PCI Presenter: John A. Bittl, Daniel I. Simon, Freek W.A. Verheugt October 30, 2016
Presentation TCT 2016 Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Re-entry vs Wire Escalation Techniques Presenter: Lorenzo Azzalini October 30, 2016
Presentation TCT 2016 In This Case: Microcirculation Assessment With CFR and IMR Was Key for Decision-making Presenter: Javier Escaned, Habib Samady, Bon-Kwon Koo October 30, 2016